Multimodality adjuvant treatment is associated with a survival benefit for patients with stage IIIC uterine carcinosarcoma

被引：0
|
作者：
Nasioudis, Dimitrios [1 ]
McMinn, Erin [1 ]
Ko, Emily [1 ]
Haggerty, Ashley [1 ]
Cory, Lori [1 ]
Giuntoli, Robert [1 ]
Kim, Sarah [1 ]
Morgan, Mark [1 ]
Latif, Nawar [1 ]
机构：
[1] Penn Med, Philadelphia, PA USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [1] Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma
    McEachron, Jennifer
    Heyman, Taryn
    Shanahan, Lisa
    Tran, Van
    Friedman, Monica
    Gorelick, Constantine
    Economos, Katherine
    Singhal, Pankaj K.
    Lee, Yi-Chun
    Kanis, Marguax J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (07) : 1012 - 1017
  • [2] Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma
    Cory, Lori
    Brensinger, Colleen
    Burger, Robert A.
    Giuntoli, Robert L., II
    Morgan, Mark A.
    Latif, Nawar
    Lin, Lilie L.
    Ko, Emily M.
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 39
  • [3] Survival after multimodality treatment for stage IIIC endometrial cancer
    Katz, LA
    Andrews, SJ
    Fanning, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (06) : 1071 - 1073
  • [4] Survival benefit of complete lymphadenectomy in patients with uterine carcinosarcoma
    Nagel, C.
    Cantrell, L.
    Havrilesky, L.
    Alvarez-Secord, A.
    Fader, A. Nickles
    Cohn, D.
    Wallace, A.
    Rose, P.
    Gehrig, P.
    O'Malley, D.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S70 - S71
  • [5] Addition of external beam radiation therapy to adjuvant chemotherapy is associated with a survival benefit for patients with stage IIIC endometrioid carcinoma
    Nasioudis, Dimitrios
    Taunk, Neil
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Morgan, Mark
    Latif, Nawar
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S81 - S81
  • [6] Differences in overall survival associated with type and sequence of adjuvant therapy in stage I uterine carcinosarcoma
    Cory, L.
    Brensinger, C. M.
    Haggerty, A. F.
    Giuntoli, R. L., II
    Latif, N. A.
    Burger, R. A.
    Morgan, M. A.
    Lin, L. L.
    Ko, E. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 207 - 207
  • [7] Outcomes of Multimodality Adjuvant Therapy in Patients with Surgically Staged Uterine Carcinosarcoma (UC)
    Hasan, Y.
    Tait, L.
    Hasselle, M.
    Meriwether, A.
    Wroblewski, K.
    Herman, L.
    Yamada, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S417 - S418
  • [8] The dilemma of adjuvant treatment for uterine carcinosarcoma
    Herbolsheimer, M.
    ONKOLOGE, 2009, 15 (10): : 1031 - 1032
  • [9] Does chemotherapy or radiation benefit surgical stage I uterine carcinosarcoma patients?
    Chow, Stephanie
    Chan, John K.
    Kapp, Daniel S.
    Mann, Amandeep
    Liou, Wen-Shiung
    Liao, Cheng-I
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (04) : 383 - 384
  • [10] Effect of treatment of patients with early-stage uterine carcinosarcoma
    Cantrell, L. A.
    Havrilesky, L.
    O'Malley, D.
    Liotta, M.
    Secord, A. A.
    Nagel, C.
    Fader, A. N.
    Wallace, A.
    Rose, P.
    Gehrig, P. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345